Parkway Life Real Estate Investment Trust (PRKWF)
PRKWF Stock Price Chart
Explore Parkway Life Real Estate Investment Trust interactive price chart. Choose custom timeframes to analyze PRKWF price movements and trends.
PRKWF Company Profile
Discover essential business fundamentals and corporate details for Parkway Life Real Estate Investment Trust (PRKWF) to support your stock research and investment decisions.
Sector
Real Estate
Industry
REIT - Healthcare Facilities
IPO Date
21 Apr 2011
Employees
—
Website
https://www.plifereit.comCEO
Yean Chau Yong
Description
Parkway Life Real Estate Investment Trust ("PLife REIT") is one of Asia's largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices). PLife REIT owns a well-diversified portfolio of 54 properties located in the Asia Pacific region, with a total portfolio size of approximately S$2.02 billion3 as at 31 December 2020. It owns the largest portfolio of strategically-located private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has 50 assets of high quality nursing home and care facility properties in various prefectures of Japan. It also owns strata-titled units/lots in MOB Specialist Clinics Kuala Lumpur in Malaysia.
PRKWF Financial Timeline
Browse a chronological timeline of Parkway Life Real Estate Investment Trust corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 20 Jan 2026
Earnings released on 6 Aug 2025
EPS came in at $0.05 , while revenue for the quarter reached $61.56M .
Dividend declared on 6 Aug 2025
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 9 Sept 2025.
Earnings released on 30 Apr 2025
Earnings released on 5 Feb 2025
Revenue for the quarter reached $53.32M .
Dividend declared on 5 Feb 2025
A dividend of $0.01 per share was announced, adjusted to $0.02. The dividend was paid on 11 Mar 2025.
Earnings released on 22 Jan 2025
Dividend declared on 22 Oct 2024
A dividend of $0.03 per share was announced, adjusted to $0.04. The dividend was paid on 26 Nov 2024.
Earnings released on 26 Jul 2024
EPS came in at $0.03 , while revenue for the quarter reached $26.64M .
Dividend declared on 26 Jul 2024
A dividend of $0.04 per share was announced, adjusted to $0.06. The dividend was paid on 30 Aug 2024.
Earnings released on 30 Apr 2024
EPS came in at $0.03 , while revenue for the quarter reached $26.85M .
Earnings released on 1 Feb 2024
EPS came in at $0.07 , while revenue for the quarter reached $111.37M .
Dividend declared on 1 Feb 2024
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 7 Mar 2024.
Earnings released on 31 Dec 2023
EPS came in at $0.04 , while revenue for the quarter reached $27.62M .
Dividend declared on 26 Jul 2023
A dividend of $0.05 per share was announced, adjusted to $0.06. The dividend was paid on 30 Aug 2023.
Earnings released on 30 Jun 2023
EPS came in at $0.03 , while revenue for the quarter reached $27.39M .
Earnings released on 31 Mar 2023
EPS came in at $0.03 , while revenue for the quarter reached $28.09M .
Earnings released on 27 Jan 2023
EPS came in at -$0.04 , while revenue for the quarter reached $30.46M .
Dividend declared on 27 Jan 2023
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 28 Feb 2023.
Earnings released on 31 Oct 2022
EPS came in at $0.03 , while revenue for the quarter reached $20.07M .
Earnings released on 8 Aug 2022
EPS came in at $0.03 , while revenue for the quarter reached $21.18M .
Dividend declared on 8 Aug 2022
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 12 Sept 2022.
Earnings released on 22 Apr 2022
EPS came in at $0.03 , while revenue for the quarter reached $22.62M .
Dividend declared on 31 Jan 2022
A dividend of $0.01 per share was announced, adjusted to $0.03. The dividend was paid on 28 Feb 2022.
Earnings released on 24 Jan 2022
EPS came in at $0.03 , while revenue for the quarter reached $22.63M .
Dividend declared on 24 Jan 2022
A dividend of $0.02 per share was announced, adjusted to $0.02. The dividend was paid on 28 Feb 2022.
Dividend declared on 11 Nov 2021
A dividend of $0.01 per share was announced, adjusted to $0.03. The dividend was paid on 8 Dec 2021.
Earnings released on 3 Nov 2021
EPS came in at $0.32 , while revenue for the quarter reached $22.47M .
Dividend declared on 27 Jul 2021
A dividend of $0.03 per share was announced, adjusted to $0.02. The dividend was paid on 31 Aug 2021.
Earnings released on 26 Jul 2021
EPS came in at $0.03 , while revenue for the quarter reached $21.94M .
Dividend declared on 23 Apr 2021
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 31 May 2021.
Earnings released on 22 Apr 2021
EPS came in at $0.04 , while revenue for the quarter reached $22.29M .
Earnings released on 25 Jan 2021
EPS came in at $0.03 , while revenue for the quarter reached $23.09M .
Dividend declared on 25 Jan 2021
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 26 Feb 2021.
Dividend declared on 11 Nov 2020
A dividend of $0.00 per share was announced, adjusted to $0.03. The dividend was paid on 8 Dec 2020.
Earnings released on 3 Nov 2020
EPS came in at $0.03 , while revenue for the quarter reached $22.11M .
PRKWF Stock Performance
Access detailed PRKWF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.